A University of Michigan poll found 60% of surveyed Medicare enrollees aged 65 and older spent under an hour reviewing coverage options.
Poll: Most Older Adults Rush Medicare Choices Despite Major Policy Changes
Browsing Category
Medication & Health Management
397 posts
Novel Imaging Method For Skin Disease Passes Early Scleroderma Test
A study of 49 people with systemic sclerosis found skin-imaging measures correlated with Rodnan scores and biopsy findings, but larger trials are needed.
Continuous Glucose Monitoring Beneficial In Type 2 Diabetes Not Treated With Insulin
In a 26-week trial, adults with type 2 diabetes not using insulin had lower HbA1c and more time in target range with continuous glucose monitoring.
Cardiac Microcurrent Therapy Raises Eyebrows In Heart Failure
Early C-MIC studies report functional improvements, but small samples and open-label designs leave efficacy and safety questions for a sham-controlled trial.
AI Has A Darker Side In Healthcare, Expert Says
At a health journalism summit, UC Berkeley researcher Mishal Khan warned AI could erode healthcare workers’ skills, autonomy and job conditions.
Scientists Discover Vanilla’s Hidden Healing Potential
Flinders University researchers report antioxidant, anti-inflammatory and antibacterial properties in vanillin, but patient testing is still needed.
Drug-Eluting Intraocular Lens Passes Test In Patients With Cataracts And Glaucoma
A 104-patient trial found a bimatoprost-releasing lens noninferior to timolol drops for lowering eye pressure after cataract surgery.
Buck Institute And Georgetown Lead Effort Mapping Harmful Protein Changes Before Disease Begins
An ARPA-H-backed, four-year effort will study disordered proteins linked to Alzheimer’s and Ewing sarcoma, pairing AI predictions with experiments.
‘Byzantine Ownership Arrangements’: Calls To Scrutinize Coding And Profit Incentives In Nursing Home Medicare Payments
MedPAC will study coding, payment accuracy and patient selection in nursing home and home health payments, with initial results expected in fall 2027.
Decades-Old Schizophrenia Drug Wins Approval For New Formulation
The FDA approved Teva’s once-monthly olanzapine injection for adults with schizophrenia, a formulation that does not require PDSS monitoring.
